ScriptLens - GLP Refill Highlighter
Overview
Highlights GLP-1 refill/intake answers that fail your clinic's criteria, with a per-case summary. Highlighting only.
ScriptLens helps clinical reviewers move faster through GLP-1 medication refill and intake cases in your review platform. As you open each case, ScriptLens reads the questionnaire and instantly highlights any answer that fails or warrants attention under your clinic's acceptance criteria: - Red — disqualifying answers (e.g. pancreatitis, insulin use, pregnancy, suicidal ideation, restricted states) - Yellow — informational flags (prior GLP-1 use with medication + dose, warfarin, prediabetes, BMI below range, age over 74, adverse reactions) A summary panel at the top of each case shows the patient's age, state, current weight and monthly loss, BMI, current GLP-1 and last dose, requested dose change, previous prescription, and current medications — and lets you jump straight to any flagged question. ScriptLens is a review aid only. It never approves, denies, submits, or changes anything on a case — the physician makes every decision. Privacy: ScriptLens runs entirely in your browser. It collects no data and transmits nothing off your device. Works across your storefronts and the "Begin Review" panel.
0 out of 5No ratings
Details
- Version1.8.2
- UpdatedJuly 15, 2026
- Offered bybryan
- Size57.74KiB
- LanguagesEnglish
- DeveloperMetaverse Ultra LLC
10712 Patina Hills Ct Las Vegas, NV 89135 USEmail
trinitynetworking@gmail.comPhone
+1 925-705-5291 - TraderThis developer has identified itself as a trader per the definition from the European Union and committed to only offer products or services that comply with EU laws.
- D-U-N-S135234611
Privacy
This developer declares that your data is
- Not being sold to third parties, outside of the approved use cases
- Not being used or transferred for purposes that are unrelated to the item's core functionality
- Not being used or transferred to determine creditworthiness or for lending purposes
Support
For help with questions, suggestions, or problems, visit the developer's support site